Ultrastructural changes of stromal cells of bone marrow and liver after cyclophosphamide treatment in mice

E Anton1

  • 1Departamento de Biología Celular e Histología, Facultad de Medicina, Universidad de Buenos Aires, Paraguay, Argentina.

Tissue & Cell
|February 1, 1997
PubMed

Insights

Cyclophosphamide (CY) severely damages bone marrow and liver stromal cells, with hemopoietic cells recovering in 10 days. However, stromal cell damage persists longer, showing slower recovery than hemopoiesis.

Area of Science:

  • Hematology
  • Toxicology
  • Cell Biology

Background:

  • Cyclophosphamide (CY) is a widely used chemotherapeutic agent.
  • Understanding its impact on bone marrow and liver stromal cells is crucial for managing toxicity.
  • Stromal cells play a vital role in maintaining tissue architecture and supporting cell regeneration.

Purpose of the Study:

  • To investigate the direct effects of cyclophosphamide on bone marrow and liver stromal cells.
  • To compare the recovery timelines of hemopoietic and stromal compartments after CY treatment.
  • To assess the ultrastructural changes induced by CY in murine models.

Main Methods:

  • DBA/2 and C57BL/6 mice received a single intraperitoneal dose of cyclophosphamide (300 mg/kg).
  • Femoral bone marrow and liver tissues were collected at various time points (hours to days) post-treatment.
  • Ultrastructural observations were performed using electron microscopy on fixed tissue samples.

Main Results:

  • Massive depletion of hemopoietic cells occurred within 12 hours, with recovery by day 10.
  • Stromal cells (endothelial, reticular, macrophages) showed severe damage as early as 2 hours post-CY.
  • Liver sinusoidal endothelial and Kupffer cells were injured by 6 hours; stromal damage persisted up to 15 days, with full recovery by day 30.

Conclusions:

  • Cyclophosphamide induces transient but severe damage to both hemopoietic and stromal cells.
  • Stromal cell recovery is significantly slower than hemopoietic cell recovery after CY exposure.
  • The study highlights the resilience of hemopoiesis despite persistent damage to the stromal microenvironment.